These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 20060904)
1. Dehydroepiandrosterone as a regulator of immune cell function. Hazeldine J; Arlt W; Lord JM J Steroid Biochem Mol Biol; 2010 May; 120(2-3):127-36. PubMed ID: 20060904 [TBL] [Abstract][Full Text] [Related]
2. [Current views on the role of dehydroepiandrosterone in physiology, pathology and therapy]. Krysiak R; Frysz-Naglak D; Okopień B Pol Merkur Lekarski; 2008 Jan; 24(139):66-71. PubMed ID: 18634257 [TBL] [Abstract][Full Text] [Related]
3. Dehydroepiandrosterone improves the ovarian reserve of women with diminished ovarian reserve and is a potential regulator of the immune response in the ovaries. Zhang J; Qiu X; Gui Y; Xu Y; Li D; Wang L Biosci Trends; 2015 Dec; 9(6):350-9. PubMed ID: 26781792 [TBL] [Abstract][Full Text] [Related]
5. Studies of dehydroepiandrosterone (DHEA) as a therapeutic agent in systemic lupus erythematosus. Van Vollenhoven RF; McGuire JL Ann Med Interne (Paris); 1996; 147(4):290-6. PubMed ID: 8952750 [TBL] [Abstract][Full Text] [Related]
6. Six-month oral dehydroepiandrosterone supplementation in early and late postmenopause. Stomati M; Monteleone P; Casarosa E; Quirici B; Puccetti S; Bernardi F; Genazzani AD; Rovati L; Luisi M; Genazzani AR Gynecol Endocrinol; 2000 Oct; 14(5):342-63. PubMed ID: 11109974 [TBL] [Abstract][Full Text] [Related]
8. Effects of dehydroepiandrosterone supplement on health-related quality of life in glucocorticoid treated female patients with systemic lupus erythematosus. Nordmark G; Bengtsson C; Larsson A; Karlsson FA; Sturfelt G; Rönnblom L Autoimmunity; 2005 Nov; 38(7):531-40. PubMed ID: 16373258 [TBL] [Abstract][Full Text] [Related]
9. Dehydroepiandrosterone, a sex steroid metabolite in development for systemic lupus erythematosus. Merrill JT Expert Opin Investig Drugs; 2003 Jun; 12(6):1017-25. PubMed ID: 12783605 [TBL] [Abstract][Full Text] [Related]
10. DHEA, important source of sex steroids in men and even more in women. Labrie F Prog Brain Res; 2010; 182():97-148. PubMed ID: 20541662 [TBL] [Abstract][Full Text] [Related]
11. [Focus on dehydroepiandrosterone (DHEA)]. Meyer P; Meier CA Rev Med Suisse; 2005 Feb; 1(6):415-8. PubMed ID: 15786645 [TBL] [Abstract][Full Text] [Related]
12. Dehydroepiandrosterone and diseases of aging. Watson RR; Huls A; Araghinikuam M; Chung S Drugs Aging; 1996 Oct; 9(4):274-91. PubMed ID: 8894525 [TBL] [Abstract][Full Text] [Related]
13. Dehydroepiandrosterone in systemic lupus erythematosus: relationship between dosage, serum levels, and clinical response. Barry NN; McGuire JL; van Vollenhoven RF J Rheumatol; 1998 Dec; 25(12):2352-6. PubMed ID: 9858429 [TBL] [Abstract][Full Text] [Related]
14. Are alterations of lymphocyte subpopulations in polymicrobial sepsis and DHEA treatment mediated by the tumour necrosis factor (TNF)-alpha receptor (TNF-RI)? A study in TNF-RI (TNF-RI(-/-)) knock-out rodents. Hildebrand F; Pape HC; Harwood P; Wittwer T; Krettek C; van Griensven M Clin Exp Immunol; 2004 Nov; 138(2):221-9. PubMed ID: 15498030 [TBL] [Abstract][Full Text] [Related]
15. The Dehydroepiandrosterone And WellNess (DAWN) study: research design and methods. von Mühlen D; Laughlin GA; Kritz-Silverstein D; Barrett-Connor E Contemp Clin Trials; 2007 Feb; 28(2):153-68. PubMed ID: 16784898 [TBL] [Abstract][Full Text] [Related]
16. Hormones and lupus: defective dehydroepiandrosterone activity induces impaired interleukin-2 activity of T lymphocytes in patients with systemic lupus erythematosus. Suzuki N; Suzuki T; Sakane T Ann Med Interne (Paris); 1996; 147(4):248-52. PubMed ID: 8952743 [TBL] [Abstract][Full Text] [Related]